Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Agent-Based Computational Model of Skeletal Muscle Investigates Muscle-Specific Responses to Disuse-Induced Muscle Atrophy.

Martin KS, Blemker SS, Peirce-Cottler SM.

J Appl Physiol (1985). 2015 Feb 26:jap.01150.2014. doi: 10.1152/japplphysiol.01150.2014. [Epub ahead of print]

PMID:
25722379
2.

Enhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling.

Call JA, Chain KH, Martin KS, Lira VA, Okutsu M, Zhang M, Yan Z.

Circ Heart Fail. 2015 Jan;8(1):188-97. doi: 10.1161/CIRCHEARTFAILURE.114.001540. Epub 2014 Dec 11.

PMID:
25504759
3.

Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction.

Brendel M, Högenauer M, Delker A, Sauerbeck J, Bartenstein P, Seibyl J, Rominger A; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Mar;108:450-9. doi: 10.1016/j.neuroimage.2014.11.055. Epub 2014 Dec 4.

PMID:
25482269
4.

Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement.

Leung KK, Malone IM, Ourselin S, Gunter JL, Bernstein MA, Thompson PM, Jack CR Jr, Weiner MW, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Feb 15;107:46-53. doi: 10.1016/j.neuroimage.2014.11.049. Epub 2014 Dec 4.

PMID:
25481794
5.

The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.

Dowling NM, Johnson SC, Gleason CE, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Jan 15;105:357-68. doi: 10.1016/j.neuroimage.2014.10.050. Epub 2014 Oct 29.

PMID:
25450107
6.

Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders.

Iturria-Medina Y, Sotero RC, Toussaint PJ, Evans AC; Alzheimer's Disease Neuroimaging Initiative.

PLoS Comput Biol. 2014 Nov 20;10(11):e1003956. doi: 10.1371/journal.pcbi.1003956. eCollection 2014 Nov.

7.

Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.

Moradi E, Pepe A, Gaser C, Huttunen H, Tohka J; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Jan 1;104:398-412. doi: 10.1016/j.neuroimage.2014.10.002. Epub 2014 Oct 12.

PMID:
25312773
8.

Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry.

Shi J, Stonnington CM, Thompson PM, Chen K, Gutman B, Reschke C, Baxter LC, Reiman EM, Caselli RJ, Wang Y; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Jan 1;104:1-20. doi: 10.1016/j.neuroimage.2014.09.062. Epub 2014 Oct 5.

PMID:
25285374
9.

Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.

Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2014 Sep;20(8):836-47. doi: 10.1017/S135561771400068X. Epub 2014 Aug 26.

10.

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

Paterson RW, Bartlett JW, Blennow K, Fox NC; Alzheimer's Disease Neuroimaging Initiative, Shaw LM, Trojanowski JQ, Zetterberg H, Schott JM.

Transl Psychiatry. 2014 Jul 29;4:e419. doi: 10.1038/tp.2014.58.

11.

Altered effective connectivity patterns of the default mode network in Alzheimer's disease: an fMRI study.

Zhong Y, Huang L, Cai S, Zhang Y, von Deneen KM, Ren A, Ren J; Alzheimer's Disease Neuroimaging Initiative.

Neurosci Lett. 2014 Aug 22;578:171-5. doi: 10.1016/j.neulet.2014.06.043. Epub 2014 Jul 1.

PMID:
24996191
12.

Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial.

Drye LT, Spragg D, Devanand DP, Frangakis C, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

PLoS One. 2014 Jun 10;9(6):e98426. doi: 10.1371/journal.pone.0098426. eCollection 2014.

13.

Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.

Pérez-Palma E, Bustos BI, Villamán CF, Alarcón MA, Avila ME, Ugarte GD, Reyes AE, Opazo C, De Ferrari GV; Alzheimer's Disease Neuroimaging Initiative; NIA-LOAD/NCRAD Family Study Group.

PLoS One. 2014 Apr 22;9(4):e95413. doi: 10.1371/journal.pone.0095413. eCollection 2014.

14.

Automatic ROI selection in structural brain MRI using SOM 3D projection.

Ortiz A, Górriz JM, Ramírez J, Martinez-Murcia FJ; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2014 Apr 11;9(4):e93851. doi: 10.1371/journal.pone.0093851. eCollection 2014.

15.

What role do local grocery stores play in urban food environments? A case study of Hartford-Connecticut.

Martin KS, Ghosh D, Page M, Wolff M, McMinimee K, Zhang M.

PLoS One. 2014 Apr 9;9(4):e94033. doi: 10.1371/journal.pone.0094033. eCollection 2014.

16.

Testing for association with multiple traits in generalized estimation equations, with application to neuroimaging data.

Zhang Y, Xu Z, Shen X, Pan W; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2014 Aug 1;96:309-25. doi: 10.1016/j.neuroimage.2014.03.061. Epub 2014 Apr 1.

PMID:
24704269
17.

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR Jr, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2014 May;137(Pt 5):1550-61. doi: 10.1093/brain/awu043. Epub 2014 Mar 12.

PMID:
24625697
18.

Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.

19.

Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.

Okutsu M, Call JA, Lira VA, Zhang M, Donet JA, French BA, Martin KS, Peirce-Cottler SM, Rembold CM, Annex BH, Yan Z.

Circ Heart Fail. 2014 May;7(3):519-30. doi: 10.1161/CIRCHEARTFAILURE.113.000841. Epub 2014 Feb 12.

PMID:
24523418
20.

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.

Mattsson N, Insel P, Tosun D, Zhang J, Jack CR Jr, Galasko D, Weiner M; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2013 Dec 31;8(12):e85443. doi: 10.1371/journal.pone.0085443. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk